Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor
暂无分享,去创建一个
A. Ruano-Raviña | F. González-Barcala | L. Valdés | N. Rodríguez-Núñez | A. Lama | L. Ferreiro | J. Ricoy | J. Álvarez-Dobaño | J. Suárez-Antelo | M. E. Toubes | C. Rábade | A. Golpe | Tamara Lourido | M. Toubes | T. Lourido | J. Suárez-Antelo | N. Rodríguez-Núñez | L. Valdés
[1] M. Humbert,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.
[2] M. Movahed,et al. Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism. , 2019, Respiratory investigation.
[3] T. Münzel,et al. Impact of symptomatic atherosclerosis in patients with pulmonary embolism. , 2019, International journal of cardiology.
[4] J. Gallacher,et al. Cardiovascular Risk Factors Associated With Venous Thromboembolism , 2019, JAMA cardiology.
[5] Thomas Kahan,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[6] C. Auger,et al. Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry. , 2018, International journal of cardiology.
[7] P. Bossuyt,et al. Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism , 2017, Annals of Internal Medicine.
[8] A. Ruano-Raviña,et al. Factors Influencing Hospital Stay for Pulmonary Embolism. A Cohort Study. , 2017, Archivos de bronconeumologia.
[9] Lina Badimon,et al. Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias , 2017 .
[10] J. Manson,et al. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies. , 2017, Circulation.
[11] B. Tamizifar,et al. Comparing three clinical prediction rules for primarily predicting the 30-day mortality of patients with pulmonary embolism: The “Simplified Revised Geneva Score,” the “Original PESI,” and the “Simplified PESI” , 2016, Advanced biomedical research.
[12] W. Ageno,et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH , 2016, Journal of thrombosis and haemostasis : JTH.
[13] W. Ageno,et al. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation , 2014, Thrombosis and Haemostasis.
[14] John A. Heit,et al. The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.
[15] D. Fitzmaurice,et al. [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. , 2014, Kardiologia polska.
[16] Jeroen J. Bax,et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .
[17] S. Suissa,et al. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. , 2013, The American journal of medicine.
[18] D. Xavier,et al. Low-dose aspirin for preventing recurrent venous thromboembolism. , 2012, The New England journal of medicine.
[19] H. Kluin-Nelemans,et al. Infections and inflammatory diseases as risk factors for venous thrombosis , 2012, Thrombosis and Haemostasis.
[20] P. Scarabin,et al. Risk assessment for recurrent venous thrombosis , 2011, The Lancet.
[21] Lisa Moores,et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. , 2010, Archives of internal medicine.
[22] G. Jensen,et al. Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study , 2010, Circulation.
[23] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[24] Cecilia Becattini,et al. Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis , 2008, Circulation.
[25] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.
[26] R. Schmieder,et al. Guidelines for management of arterial hypertension , 2007 .
[27] M. Prins,et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis , 2006, Journal of thrombosis and haemostasis : JTH.
[28] W. Ageno,et al. A prospective study on cardiovascular events after acute pulmonary embolism. , 2005, European heart journal.
[29] J. Eriksson,et al. The risk of venous thromboembolism is markedly elevated in patients with diabetes , 2005, Diabetologia.
[30] B. Psaty,et al. Serum Lipid Levels and the Risk of Venous Thrombosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[31] T. Baglin,et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study , 2003, The Lancet.
[32] T. Aitman,et al. A novel role for CD36 in VLDL-enhanced platelet activation. , 2003, Diabetes.
[33] M. Prins,et al. An association between atherosclerosis and venous thrombosis. , 2003, The New England journal of medicine.
[34] D. Corella,et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors , 2002, British journal of haematology.
[35] E. Oger. Incidence of Venous Thromboembolism: A Community-based Study in Western France , 2000, Thrombosis and Haemostasis.
[36] W M O'Fallon,et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.
[37] Samuel Z Goldhaber,et al. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.
[38] F. Rosendaal. Venous thrombosis: a multicausal disease , 1999, The Lancet.
[39] Jeffrey S. Ginsberg,et al. The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism , 1998, Annals of Internal Medicine.
[40] J. Remy,et al. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique--comparison with pulmonary angiography. , 1992, Radiology.
[41] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[42] P. Investigators,et al. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). , 1990, JAMA.
[43] C K Wells,et al. Evaluation of clinical methods for rating dyspnea. , 1988, Chest.
[44] J. Gore,et al. Occult malignant neoplasm in patients with deep venous thrombosis. , 1987, Archives of internal medicine.